Antirheumatics Pharmaceutical Market

Antirheumatics Pharmaceutical Market: Introduction

• Individuals with incendiary joint inflammation live full dynamic lives because of ailment altering antirheumatic medications, or DMARDs. This factor boosts the growth of the global antirheumatics pharmaceutical market.

Key Drivers and Opportunities of Global Antirheumatics Pharmaceutical Market

• The global antirheumatics pharmaceutical market is driven by the aging population in major countries. Moreover, access to quality social insurance and pharmaceuticals to poor and white-collar class families propels the global antirheumatics pharmaceutical industry. Rise in focus of pharmaceutical companies to tap the rare and chronic diseases augments the global market. Developments in innovative biologics, nucleic corrosive therapeutics, and cell treatment boosts the growth of the global antirheumatics pharmaceutical market.
• Adoption of cost control strategies and standards set by governments in major countries fuel the growth of the global antirheumatics pharmaceutical market. Antirheumatics organizations are compelled to lessen their R&D spending because of logjam of development in the past few years, which is expected to hamper the growth of the global antirheumatics pharmaceutical market.

North America to Dominate Global Antirheumatics Pharmaceutical Market

• In terms of region, the global antirheumatics pharmaceutical market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
• North America is projected to dominate the global antirheumatics pharmaceutical market during the forecast period. Significant focus of key players in development of new products is anticipated augment the market in the region. Moreover, presence of key players and surge in number of patients with rheumatoid arthritis is expected to boost the growth of the market in North America. According to the Centers for Disease Control and Prevention, 22.7% of the adults in the U.S. had arthritis between 2013 and 2015.
• The antirheumatics pharmaceutical market in Asia Pacific is likely to grow at a rapid pace during the forecast period owing to surge in the geriatric population. Moreover, investment by key players is likely to create significant opportunities in the market in the region. For instance, in March 2019, Astellas Pharma, Inc. announced the approval for Smyraf in Japan for the treatment of rheumatoid arthritis.

Key Players Operating in Global Antirheumatics Pharmaceutical Market

The global antirheumatics pharmaceutical market is fragmented due to the presence of large number of international and local players. A large number of manufacturers hold major share in their respective regions. Demand for antirheumatics pharmaceutical products has increased in emerging as well as developed markets owing to rise in awareness and prevalence of rheumatoid arthritis. Growth strategies adopted by leading players are likely to drive the global market. For instance, in September 2020, Lupin launched Leflunomide generic drug in the U.S. In June 2020, AbbVie's Rinvoq received the FDA approval to treat rheumatoid arthritis.

Key players operating in the global antirheumatics pharmaceutical market are:

• AbbVie
• Amgen, Inc.
• Pfizer, Inc.
• F. Hoffmann-La Roche Ltd.
• Novartis AG
• Bristol-Myers Squibb Company
• UCB S.A.
• Eli Lilly and Company
• Celgene Corporation
• Johnson & Johnson
• GlaxoSmithKline plc
• LUPIN
• Bayer AG

Global Antirheumatics Pharmaceutical Market: Research Scope

Global Antirheumatics Pharmaceutical Market, by Products

• Non-steroidal Anti-Inflammatory Drugs
• Steroidal Anti-inflammatory Drugs
• Disease Modifying Anti-rheumatic Drugs (DMARDs)
• Others

Global Antirheumatics Pharmaceutical Market, by Route of Administration

• Oral
• Injectable

Global Antirheumatics Pharmaceutical Market, by Rheumatoid Arthritis

• Seropositive RA
• Seronegative RA

Global Antirheumatics Pharmaceutical Market, by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Antirheumatics Pharmaceutical Market, by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa